Skip to main content
logo
Edwards Lifesciences logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
85.21
+0.97 (1.15%)
At close: Oct 9, 2026, 4:00 PM EDT
85.00
-0.21 (-0.25%)
After-hours: Oct 9, 2026, 7:38 PM EDT

Edwards Lifesciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6,5126,0685,4405,0104,4645,233
Revenue Growth
14.55%11.55%8.57%12.23%-14.69%19.29%
Gross Profit
5,0694,7334,3224,0323,7423,984
Operating Income
1,8311,6381,4811,4871,5421,587
Net Income
1,0051,0744,1751,4021,5221,503
Earnings Per Share
1.721.836.972.302.442.38
EPS Growth
-75.50%-73.70%202.39%-5.44%2.40%83.08%

Revenue by Segment
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Transcatheter Aortic Valve Replacement
4,7664,4884,1063,8803,5183,423
Transcatheter Mitral and Tricuspid Therapies
674.6550.6352.1197.6116.186
Surgical Structural Heart
1,0721,029981.3932.6829.7889.1
Revenue (Total)
6,5126,0685,4405,0104,4645,233

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,2824,2333,9811,6331,2151,467
Total Debt
704.4705.4700685.1691.3690.3
Net Cash (Debt)
3,5773,5283,281947.7524776.5
Net Cash Growth
6.31%7.51%246.25%80.86%-32.52%9.72%
Net Cash Per Share
6.156.025.481.560.841.23

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7201,595542.3895.81,2181,732
Capital Expenditures
-286.7-260.2-252.4-253-244.6-325.8
Free Cash Flow
1,4341,335289.9642.8973.61,406
Free Cash Flow Growth
143.85%360.50%-54.90%-33.98%-30.77%117.26%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
77.84%78.01%79.46%80.47%83.82%76.13%
Operating Margin
28.12%26.99%27.22%29.69%34.54%30.32%
Pretax Margin
21.77%20.98%28.46%27.39%34.04%32.53%
Profit Margin
15.43%17.69%76.75%27.99%34.09%28.73%
FCF Margin
22.01%22.00%5.33%12.83%21.81%26.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
50.8446.0810.4632.9830.3153.81
Forward PE
27.1430.9331.1928.4130.3552.98
P/FCF Ratio
34.2637.06150.6171.9447.3857.51
PS Ratio
7.548.158.039.2310.3315.46